Dozens of people sue GLP-1 drug companies over alleged vision loss

Diabetes and weight-loss medications are believed by some to be the cause of their mysterious loss of vision.Dozens of people have filed lawsuits in the United States against GLP-1 companies, which make popular weight-loss drugs like Ozempic and Mounjaro, claiming their products caused a rare condition that can cause permanent vision loss, US media outlets report.The cases and alleged risk could present a significant challenge to a fledgling industry that analysts expected to generate about $100bn in annual sales in the next 10 years after being taken by millions of people in the US and making inroads into combatting widespread obesity in the country.Recommended Stories list of 3 itemslist 1 of 3WeightWatchers files for bankruptcy amid rise of weight-loss drugslist 2 of 3Could weight loss drugs fix UK’s unemployment problem?list 3 of 3Wegovy maker Novo Nordisk to slash thousands of jobsend of listA spokesperson for Novo Nordisk, the pharmaceutical giant that makes Wegovy and Ozempic, said the lawsuits lacked merit and the company was vigorously contesting them, according to The Wall Street Journal, while Eli Lilly, which produces Zepbound, did not comment on the litigation but said...